A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM SmalCap 60: Valeo Pharma Aims To Build a First-Rate Top-Tier Canadian Company

Share
New Message
Please login to post a reply